Role of fusion protein cleavage site in the virulence of Newcastle disease virus

Microbial Pathogenesis

Volumn 36, Issue 1, 2004, Pages 1-10

  Panda, Aruna ^a   Huang, Zhuhui ^a   Elankumaran, Subbiah ^a   Rockemann, Daniel D ^a   Samal, Siba K ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

Fusion protein cleavage site; Newcastle disease virus; Reverse genetics

Indexed keywords

AMINO ACID; HYBRID PROTEIN; PROTEINASE; VIRUS ENZYME;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CHICKEN; CONTROLLED STUDY; GENETIC PROCEDURES; MUTATION; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS STRAIN; VIRUS VIRULENCE;

GALLUS GALLUS; NEWCASTLE DISEASE VIRUS;

EID: 0345256555     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micpath.2003.07.003     Document Type: Article

References (36)

1. Mayo M.A. A summary of taxonomic changes recently approved by ICTV. Arch Virol. 147:(8):2002;1655-1656.
2. Alexander D.J. Newcastle disease. In: A laboratory manual for the isolation and identification of avian pathogens. 1989;The American Association of Avian Pathologists, Kendall/Hunt Publishing Company, Dubuque, IA. p. 114-120.
3. Krishnamurthy S., Samal S.K. Nucleotide sequences of the trailer, nucleocapsid protein genome sequence. J Gen Virol. 79:1997;2419-2424.
4. Peeples M.E. Newcastle disease virus replication. Alexander D.J. Newcastle disease. 1988;45-78 Kluwer Academic Publihsers, Dordrecht.
5. Steward M., Vipoond B., Miller N.S., Emmerson P.T. RNA editing in Newcastle disease virus. J Gen Virol. 74:1993;2539-2547.
6. Scheid A., Choppin P.W. Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity by proteolytic cleavage of an inactive protein of Sendai virus. Virology. 57:1974;470-490.
7. Sergel-Germano T., McQuain C., Morrison T.G. Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion. J Virol. 68:1994;7654-7658.
8. Gotoh B., Ohnishi Y., Inocencio N.M., Esaki E., Nakayama K., Barr P.J., Thomas G., Nagai Y. Mammalian subtilisin-related proteinases in cleavage activation of the paramyxovirus fusion glycoproteins: superiority of furin/PACE to PC2 or PC1/PC3. J Virol. 66:1992;6391-6397.
9. Fujii Y., Sakaguchi T., Kiyotani K., Yoshida T. Comparison of substrate specificities against the fusion glycoprotein of virulent Newcastle disease virus between a chick embryo fibroblast processing protease and mammalian subtilisin-like proteases. Microbiol Immunol. 43:(2):1999;133-140.
10. Millar N.S., Chambers P., Emmerson P.T. Nucleotide sequence of the fusion and hemagglutinin-neuraminidase glycoprotein genes of Newcastle disease virus, strain Ulster: molecular basis for variations in pathogenicity between strains. J Gen Virol. 69:1988;613-620.
11. Seal B.S., King D.J., Bennett J.B. Characterization of Newcastle disease virus isolates by RT-PCR coupled to direct nucleotide sequencing and development of sequence database for pathotype prediction and molecular epidemiologic analysis. J Clin Microbiol. 33:1995;2624-2630.
12. Huang Z., Krishnamurthy S., Panda A., Samal S.K. High-level expression of a foreign gene from the most 3′-proximal locus of a recombinant Newcastle disease virus. J Gen Virol. 82:2001;1729-1736.
13. Collins M.S., Strong I., Alexander D.J. Pathogenicity and phylogenetic evaluation of the variant Newcastle disease viruses termed pigeon PMV-1 viruses based on the nucleotide sequence of the fusion protein gene. Arch Virol. 141:1996;635-647.
14. Peeters B.P., De Leeuw O.S., Koch G., Gielkens A.L. Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol. 73:1999;5001-5009.
15. Taubenberger J.K., Reid A.H., Krafft A.E., Bijwaard K.E., Fanning T.G. Initial genetic characterization of the 1918 Spanish influenza virus. Science. 275:1997;1793-1796.
16. Cabaleda C., Munoz-Barroso I., Sagrera A., Villar E. Fusogenic activity of reconstituted Newcastle disease virus envelopes: a role for the hemagglutinin-neuraminidase protein in the fusion process. Int J Biochem Cell Biol. 34:(4):2002;403-413.
17. Mebatsion T., Verstegen S., De Vaan L.T., Romer-Oberdorfer A., Schrier C.C. A recombinant Newcastle disease virus with low-level V protein expression is immunogenic and lacks pathogenicity for chicken embryos. J Virol. 75:(1):2001;420-428.
18. Park M.S., Shaw M.L., Munoz-Jordan J., Cros J.F., Nakaya T., Bouvier N., Palase P., Garcia-Sastre A., Basler C.F. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonistic ativity for the NDV V protein and the Nipah virus V, W, and C proteins. J Virol. 77:(2):2003;1501-1511.
19. Takimoto T., Taylor G.L., Connaris H.C., Crennell S.J., Portner A. Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxo-cell membrane fusion. J Virol. 76:(24):2002;13028-13033.
20. Duprex W.P., Duffy I., McQuaid S., Hamill L., Cosby S.L., Billeter M.A., Schneider-Schaulies J., Ter Meulen V., Rima B.K. The H gene of rodent brain-adapted measles virus confers neurovirulence to the Edmonston vaccine strain. J Virol. 73:1999;6916-6922.
21. Skiadopoulos M.H., Surman S., Tatem J.M., Paschalis M., Wu S.L., Udem S.A., Durbin A.P., Collins P.L., Murphy B.R. Identification of mutations contributing to the temperature sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccine. J Virol. 73:1999;1374-1381.
22. Skiadopoulos M.H., Durbin A.P., Tatem J.M., Wu S.L., Paschalis M., Tao T., Collins P.L., Murphy B.R. Three amino acid substitutions in the L protein of the human parainfluenza virus type 3 cp45 live attenuated vaccine candidate contribute to its temperature-sensitive and attenuation pathotypes. J Virol. 72:1998;1762-1768.
23. Racaniello V.R., Ren R., Bouchard M.J. Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis. Dev Biol Stand. 78:1993;109-116.
24. Takeda M., Kato A., Kobune F., Sakata H., Li Y., Shioda T., Sakai Y., Asakawa M., Nagai Y. Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins. J Virol. 72:1998;8690-8696.
25. Enjuanes L., Van der Zeijst B.A.M. Molecular basis of transmissible gastroenteritis coronavirus (TGEV) epidemiology. Sidell S.G. The coronaviridae. 1995;337-376 Plenum, NY.
26. Bridgen A., Weber F., Fazakerley J.K., Elliott R.M. Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis. Proc Natl Acad Sci USA. 98:2001;664-669.
27. Heise M.T., Simpson D.A., Johnston R.E. A single amino acid change in nsP1 attenuates neurovirulence of the Sindbis-group alphavirus S.A.AR86. J Virol. 74:2000;4207-4213.
28. Yang J.S., Ramanathan M.P., Muthumani K., Choo A.Y., Jin S.H., Yu Q.C., Hwang D.S., Choo D.K., Lee M.D., Dang K., Tang W., Kim J.J. Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway. Emerg Infect Dis. 8:(12):2002;1379-1384.
29. Price G.E., Smith H., Sweet C. Differential induction of cytotoxicity and apoptosis by influenza virus strains of differing virulence. J Gen Virol. 78:1997;2821-2829.
30. Lewis J., Wesselingh S.L., Griffin D.E., Hardwick J.M. Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence. J Virol. 70:1996;1828-1835.
31. Lam K.M., Vasconcelos A.C., Bickfor A.A. Apoptosis as a cause of death in chicken embryos inoculated with Newcastle disease virus. Microb Pathog. 19:1995;169-174.
32. Lycke E., Tsiang H. Rabies virus infection of cultured rat sensory neurons. J Virol. 61:1987;2733-2741.
33. Krishnamurthy S., Huang Z., Samal S.K. Recovery of a virulent strain of Newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology. 278:2000;168-182.
34. Byrappa S., Gavin D.K., Gupta K.C. A highly efficient procedure for site-specific mutagenesis of full length plasmids using vent DNA polymerase. Genome Res. 1995;404-407.
35. Kommers G.D., King D.J., Seal B.S., Brown C.C. Virulence of pigeon-origin Newcastle disease virus isolates for domestic chickens. Avian Dis. 45:2001;906-921.
36. Lana D.P., Snyder D.B., King D.J., Marquardt W.W. Characterization of a battery of monoclonal antibodies for differentiation of Newcastle disease virus and Pigeon paramyxovirus-1 strains. Avian Dis. 32:1988;273-281.